Stiefel Laboratories Inc. and Charles W. Stiefel: Lit. Rel ...

On December 12, 2011, the Securities and Exchange Commission filed securities fraud charges against Stiefel Laboratories Inc. (at the time of its misconduct the world’s largest private manufacturer of dermatology products, and now a fully-owned subsidiary of GlaxoSmithKline PLC) and Charles Stiefel, its former chairman and CEO, alleging they ...

Alexa Traffic


Listing Links